The FDA has granted an orphan drug designation to gunagratinib as a potential th
- This topic has 0 replies, 1 voice, and was last updated 3 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The FDA has granted an orphan drug designation to gunagratinib as a potential therapeutic option for patients with cholangiocarcinoma.
https://clinicaltrials.gov/ct2/show/NCT03758664
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.